Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The pituitary adenylate cyclase-activating polypeptide receptor PAC1 (PAC1R) is a G protein-coupled receptor that binds PACAP with high affinity. It belongs to the class B family of GPCRs and undergoes extensive alternative splicing, resulting in several isoforms with differing signaling properties. PAC1R is widely expressed throughout the central and peripheral nervous systems, as well as endocrine tissues, and plays a role in diverse physiological functions, including neuroendocrine regulation, stress response, and pain processing. Dysregulation of the PACAP/PAC1 system is implicated in psychiatric conditions like PTSD and chronic pain states such as migraine headaches.
Agonist binding leads to activation of Gs and Gq proteins, increasing cAMP and intracellular calcium levels, respectively. This further activates downstream signaling pathways such as PKA, PKC and ERK.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pituitary Adenylate Cyclase-Activating Polypeptide Receptor PAC1 (PAC1R).